| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 1476 | 2023 |
| Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019 | 490 | 2019 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 351 | 2022 |
| Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets CW Spearman, M Afihene, R Ally, B Apica, Y Awuku, L Cunha, ... The lancet gastroenterology & hepatology 2 (12), 900-909, 2017 | 319 | 2017 |
| The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm–volume 2 A Hatzakis, V Chulanov, AC Gadano, C Bergin, Z Ben‐Ari, J Mossong, ... Journal of viral hepatitis 22, 26-45, 2015 | 185 | 2015 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 176 | 2022 |
| The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? JV Lazarus, HE Mark, M Villota-Rivas, A Palayew, P Carrieri, M Colombo, ... Journal of hepatology 76 (4), 771-780, 2022 | 173 | 2022 |
| Hepatitis C treatment: where are we now? NJ Burstow, Z Mohamed, AI Gomaa, MW Sonderup, NA Cook, I Waked, ... International journal of general medicine, 39-52, 2017 | 156 | 2017 |
| Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 2 V Saraswat, S Norris, RJ De Knegt, JF Sanchez Avila, M Sonderup, ... Journal of viral hepatitis 22, 6-25, 2015 | 142 | 2015 |
| Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030 MW Sonderup, M Afihene, R Ally, B Apica, Y Awuku, L Cunha, ... The Lancet Gastroenterology & Hepatology 2 (12), 910-919, 2017 | 124 | 2017 |
| Strategies to manage hepatitis C virus (HCV) infection disease burden–volume 2 E Gane, D Kershenobich, C Seguin‐Devaux, P Kristian, I Aho, O Dalgard, ... Journal of viral hepatitis 22, 46-73, 2015 | 91 | 2015 |
| N‐acetylcysteine for non‐paracetamol drug‐induced liver injury: a systematic review MF Chughlay, N Kramer, CW Spearman, M Werfalli, K Cohen British Journal of Clinical Pharmacology 81 (6), 1021-1029, 2016 | 80 | 2016 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ... The Lancet Gastroenterology & Hepatology 8 (10), 879-907, 2023 | 73 | 2023 |
| Innovative strategies for the elimination of viral hepatitis at a national level: a country case series SE Schröeder, A Pedrana, N Scott, D Wilson, C Kuschel, L Aufegger, ... Liver International 39 (10), 1818-1836, 2019 | 63 | 2019 |
| DNA Oncogenic Virus‐Induced Oxidative Stress, Genomic Damage, and Aberrant Epigenetic Alterations MM Kgatle, CW Spearman, AA Kalla, HN Hairwadzi Oxidative medicine and cellular longevity 2017 (1), 3179421, 2017 | 56 | 2017 |
| The expression of MUC mucin in cholangiocarcinoma AS Mall, MG Tyler, SB Ho, JEJ Krige, D Kahn, W Spearman, L Myer, ... Pathology-Research and Practice 206 (12), 805-809, 2010 | 56 | 2010 |
| Health disparities in liver disease in sub‐Saharan Africa CW Spearman, MW Sonderup Liver International 35 (9), 2063-2071, 2015 | 55 | 2015 |
| Epidemiology of liver cancer in Africa: current and future trends E Okeke, PM Davwar, L Roberts, K Sartorius, W Spearman, A Malu, ... Seminars in liver disease 40 (02), 111-123, 2020 | 54 | 2020 |
| Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey A Scheibe, K Young, L Moses, RL Basson, A Versfeld, CW Spearman, ... Harm reduction journal 16, 1-11, 2019 | 54 | 2019 |
| Lancet Gastroenterology & Hepatology Commissioners. Accelerating the elimination of viral hepatitis: a lancet Gastroenterology & hepatology commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... Lancet Gastroenterol Hepatol 4 (2), 135-184, 2019 | 54 | 2019 |
